Canada markets open in 9 hours 17 minutes

Valneva SE (VLA.VI)

Vienna - Vienna Delayed Price. Currency in EUR
Add to watchlist
12.91+0.35 (+2.79%)
At close: 05:32PM CEST
Full screen
Previous Close12.56
Open12.94
Bid12.12 x 50000
Ask13.70 x 81200
Day's Range12.41 - 13.48
52 Week Range2.06 - 13.48
Volume917
Avg. Volume14,123
Market Cap1.163B
Beta (5Y Monthly)0.98
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Valneva SE Declaration of shares and voting rights - Interim status at June 22, 2022

    VALNEVA Declaration of shares and voting rights Interim status at June 22, 2022__________________________________________________________________________________________ Company name: VALNEVARegistered office: 6 rue Alain Bombard, 44800 Saint-Herblain (France)Regulated market of Euronext Paris - Compartment A Declaration date: June 27, 2022 Number of shares composing the share capital of Valneva Total number of voting rights including suspended voting rights* Description of the change Date on wh

  • GlobeNewswire

    Valneva Announces Successful Outcome of its AGM and Appointment of two New Supervisory Board Members

    Saint-Herblain (France), June 24, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that all the resolutions recommended by the Management Board were approved by the shareholders at its Annual General Meeting (AGM) held yesterday in Paris. Among the adopted resolutions were approval of the 2021 financial statements, delegations for the management board to increase Valneva’s share capital and/or issue financial instruments, and the appointment, fo

  • GlobeNewswire

    Valneva and Pfizer Announce Closing of Equity Investment

    Saint-Herblain (France) and New York, June 23, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and Pfizer Inc. (NYSE: PFE) today announced the closing of the equity investment announced on June 20, 2022.1 Pursuant to an Equity Subscription Agreement, Pfizer has invested €90.5 ($95) million in Valneva, representing 8.1% of Valneva’s share capital at a price of €9.49 per share, through a reserved capital increase. Valneva is planning to use the proceeds to suppo